Addus HomeCare Corp. Hits New 52-Week Low at $88.57

Addus HomeCare Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 88.57 as of June 1, 2026. This marks a significant decline, with the stock's performance over the past year showing a decrease of 23.42%, contrasting sharply with the S&P 500's gain of 28.56%. Despite this downturn, Addus HomeCare maintains a market capitalization of USD 1,882 million and exhibits a price-to-earnings (P/E) ratio of 19.00. The company is net-debt free, which positions it favorably in terms of financial stability. Additionally, it has demonstrated a healthy long-term growth trajectory, with operating profit increasing at an annual rate of 25.77%. In its latest financial results, Addus HomeCare reported an operating cash flow of USD 144.91 million, the highest recorded, while raw material costs have decreased by 0.13% year-over-year. The company's return on equity stands at 9.35%, and its price-to-book ratio is 1.79, indicating an attractive valuation relative to its peers. However, the stock has consistently underperformed against the S&P 500 over the past three years, raising questions about its market position.